Partnering & Licensing
Partnering and Licensing Opportunities
XOMA is seeking to leverage its antibody discovery and engineering technologies and capabilities through the following types of partnerships:
Please send your partnering inquiries to:
Svetlana Lucas
Director, Business Development
lucas@xoma.com
Jim Neal
Vice President, Business Development
neal@xoma.com
- Licensing or co-development agreements involving XOMA’s proprietary pipeline including gevokizumab, the XMet and oncology programs
- Collaborations to discover and develop antibody therapeutics based on challenging target classes (e.g., GPCRs) by utilizing XOMA’s proprietary integrated display system, cell panning methodologies, andModulX™technology
- Exclusive, co-exclusive, and semi-exclusive phage display library collaboration deals, enabling partners to discover and develop antibody therapeutics using XOMA’s integrated display system and favorable IP position
